Skip to Content Top

OVER $2.5 BILLION

OBTAINED FOR MESOTHELIOMA PATIENTS & FAMILIES
logo
|

Preclinical Studies Highlight uPARAP's Potential in the Treatment of Mesothelioma

Researchers in Denmark are conducting preclinical studies into the utilization of the collagen receptor uPARAP as a therapeutic target in the treatment of mesothelioma. An initial study found that the expression of uPARAP is abundant in mesothelioma and appears to have favorable properties for antibody-drug conjugate (ADC) therapy.

In vivo studies in mice with mesothelioma showed that a drug targeting uPARAP significantly delayed tumor growth and reduced tumor size compared to control groups. Expression varied within subtypes, suggesting patient stratification should be based on individual target expression rather than subtype alone. An additional project is investigating uPARAP as a target for CAR T cell therapy, but so far studies are inconclusive.

These findings highlight the potential of uPARAP as a promising therapeutic target for mesothelioma. The study represents a significant step towards developing an effective treatment modality, with uPARAP serving as a potential avenue for addressing this aggressive cancer.

Read the abstract here: The Collagen Receptor uPARAP as a Therapeutic Target for Mesothelioma

Our Mission

  • Medical Empowerment

    Get the information you need to make informed decisions about your treatment.

  • Legal Empowerment

    Get the compensation you need to address the financial cost of your illness.

  • Going For The Gold

    Helping empower our clients with over $2.5 Billion in recoveries. We fight for our clients!

  • Giving Back To The Community

    Unprecedented Support for Mesothelioma Research. See how we can help!

Get Empowered

We put your medical and personal needs first and provide compassionate representation.
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.
  • By submitting, you agree to receive text messages from Worthington & Caron, PC at the number provided, including those related to your inquiry, follow-ups, and review requests, via automated technology. Consent is not a condition of purchase. Msg & data rates may apply. Msg frequency may vary. Reply STOP to cancel or HELP for assistance. Acceptable Use Policy